At the 2025 PDF Solutions Users Conference, CEO John Kibarian delivered a wide-ranging keynote that positioned the ...

The U.S. Congress has rejected  extreme cuts in the federal energy research and development (R&D) budget proposed  [PDF] by ...

Positive Phase 3 HERIZON-GEA-01 results for Ziihera (zanidatamab-hrii) in first-line HER2-positive (HER2+) gastroesophageal adenocarcinoma (GEA) presented at ASCO GI Up to $440.0 million in milestone ...

The 43-day shutdown of the U.S. government in October and November 2025 complicated lots of things for lots of people, and ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the initiation of KANDLELIT-007, a ...

Global Venous Stents Market to grow at a CAGR of 8.36% during 2026–2033, with the U.S. maintaining leadership in North America amid increasing adoption of stent-based therapies.Austin, Texas, Jan. 12, ...

Main outcome measures Cumulative time dependent intake of preservatives, including those in industrial food brands, assessed ...

Evidence shows electric vehicle adoption is nearing a tipping point, with declining battery costs and enhanced infrastructure ...

Canada revised its medical assistance in dying (MAiD) legislation to extend eligibility to individuals without a reasonably ...

SciBase Holding AB (publ) ("SciBase" or the "Company") today announces the outcome of the repurchase offer for all warrants of series TO 2 resolved by the Board of Directors on 7 November 2025 (the ...

Phase 1b study to evaluate combination of zongertinib and zanidatamab in HER2-positive breast cancer patients Ingelheim, Germany- 12 January, 2026 - Boehringer Ingelheim today announced a strategic ...

Jennifer Simonson is a business journalist with a decade of experience covering entrepreneurship and small business. Drawing on her background as a founder of multiple startups, she writes for Forbes ...